Business
Aquestive Therapeutics to Report First Quarter 2026 Financial Results and Recent Business Highlights on May 13 and Host Conference Call on May 14 at 8:00 a.m. ET
WARREN, N.J., May 06, 2026 (GLOBE NEWSWIRE) -- Aquestive Therapeutics, Inc. (NASDAQ: AQST) (“Aquestive” or the “Company”), a pharmaceutical company advancing medicines to bring meaningful improvement to patients' lives through innovative science and delivery technologies, today announced that it will report results for the first quarter ended March 31, 2026 and provide an update on recent developments in its business after market close on Wednesday, May 13, 2026. Management will host a conferenc
About this update from Aquestive Therapeutics, Inc.
[{"type":"image","alt":"Aquestive Therapeutics, Inc.","displaySize":"","headline":null,"caption":"Aquestive Therapeutics, Inc.","className":"","disableSlideshowImg":false,"size":{"original":{"width":300,"height":77,"url":"https://media.zenfs.com/en/globenewswire.com/834883b9239a9e55bd9bebae2405df43"},"resized":{"url":"https://s.yimg.com/ny/api/res/1.2/hepRKeWnARhKgpkSXI4otQ--/YXBwaWQ9aGlnaGxhbmRlcjt3PTQyMDtoPTEwOA--/https://media.zenfs.com/en/globenewswire.com/834883b9239a9e55bd9bebae2405df43","width":300,"height":77}},"lazy":false},{"type":"text","content":"WARREN, N.J., May 06, 2026 (GLOBE NEWSWIRE) -- Aquestive Therapeutics, Inc. (NASDAQ: AQST) (“Aquestive” or the “Company”), a pharmaceutical company advancing medicines to bring meaningful improvement to patients' lives through innovative science and delivery technologies, today announced that it will report results for the first quarter ended March 31, 2026 and provide an update on recent developments in its business after market close on Wednesday, May 13, 2026.","length":471,"tagName":"p"},{"type":"text","content":"Management will host a conference call for investors at 8:00 a.m. ET on Thursday, May14, 2026. To participate, please register in advance here to obtain a local or toll-free phone number and your personal pin.","length":209,"tagName":"p"},{"type":"text","content":"A live webcast of the call will be available on the Investors section of Aquestive’s website at: First Quarter 2026 Earnings Call","length":129,"tagName":"p"},{"type":"text","content":"Following the call, a replay of the webcast will be available on the Investors section of the Company’s website at https://investors.aquestive.com/events-and-presentations. The webcast will be archived for 30 days.","length":214,"tagName":"p"},{"type":"text","content":"About Aquestive Therapeutics Aquestive is a pharmaceutical company advancing medicines to bring meaningful improvement to patients' lives through innovative science and delivery technologies. The worldwide leader in delivering trusted, quality medications on oral film, Aquestive operates as both a developer of its own proprietary products and a Contract Development and Manufacturing Organization (CDMO) for licensees, with its headquarters in New Jersey and U.S.-based manufacturing facilities in Indiana. The Company is the exclusive manufacturer of four commercialized product...